Literature DB >> 12799242

Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa.

José García-Arumí1, Vicente Martinez, Laura Sararols, Borja Corcostegui.   

Abstract

PURPOSE: To evaluate the anatomic and functional outcome of vitreoretinal surgery in eyes with retinitis pigmentosa (RP) and macular edema.
DESIGN: Prospective noncomparative case series. PARTICIPANTS: Twelve consecutive eyes of eight patients with RP and a documented decrease in visual acuity (VA) to 20/60 or worse caused by macular edema refractory to medical therapy.
METHODS: Pars plana vitrectomy was performed in the 12 eyes, followed by posterior hyaloid dissection, removal of the posterior inner limiting membrane after staining with indocyanine green, and gas tamponade. Preoperative best-corrected VAs ranged from 20/60 to 20/400 (mean, 20/115). MAIN OUTCOME MEASURES: Changes in VA and foveal thickness as determined by optical coherence tomography (OCT).
RESULTS: The mean preoperative retinal thickness at the fovea was 477 micro m. Optical coherence tomography showed a decrease in macular thickness of >40% in 10 eyes (83.3%), with a mean postoperative foveal thickness of 260 micro m. The mean VA increased from 20/115 to 20/45, with an average of three lines of improvement.
CONCLUSIONS: Our results suggest that vitreoretinal surgery may effectively manage macular edema in RP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799242     DOI: 10.1016/S0161-6420(03)00259-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  19 in total

1.  The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa.

Authors:  Yasuhiro Ikeda; Toshio Hisatomi; Noriko Yoshida; Shoji Notomi; Yusuke Murakami; Hiroshi Enaida; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-04       Impact factor: 3.117

2.  Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa.

Authors:  Mayer Srour; Giuseppe Querques; Nicolas Leveziel; Jennyfer Zerbib; Julien Tilleul; Elise Boulanger-Scemama; Eric H Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-29       Impact factor: 3.117

3.  Intravitreal dexamethasone implant for recalcitrant cystoid macular edema secondary to retinitis pigmentosa: a pilot study.

Authors:  Aditya Sudhalkar; Laurent Kodjikian; Nishikant Borse
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-04       Impact factor: 3.117

4.  Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis.

Authors:  Chen Chen; Xia Liu; Xiaoyan Peng
Journal:  Front Med (Lausanne)       Date:  2022-05-16

5.  Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa.

Authors:  Giuseppe Querques; Francesco Prascina; Cristiana Iaculli; Nicola Delle Noci
Journal:  Int Ophthalmol       Date:  2007-12-22       Impact factor: 2.031

6.  Transient tractional retinal detachment in an eye with retinitis pigmentosa.

Authors:  Shuichiro Hirahara; Yoshio Hirano; Tsutomu Yasukawa; Yuichiro Ogura
Journal:  Clin Ophthalmol       Date:  2010-10-05

7.  Vitrectomy with internal limiting membrane removal for clinically significant macular oedema.

Authors:  Ferenc Kuhn; Gyöngyi Kiss; Viktória Mester; Zsuzsanna Szijártó; Bálint Kovács
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-02-18       Impact factor: 3.117

8.  Tangential vitreous traction: a possible mechanism of development of cystoid macular edema in retinitis pigmentosa.

Authors:  Mikiko Takezawa; Soichi Tetsuka; Akihiro Kakehashi
Journal:  Clin Ophthalmol       Date:  2011-02-21

Review 9.  Intravitreal aflibercept (Eylea) injection for cystoid macular edema secondary to retinitis pigmentosa - a first case report and short review of the literature.

Authors:  Giannis-Aimant Moustafa; Marilita M Moschos
Journal:  BMC Ophthalmol       Date:  2015-04-30       Impact factor: 2.209

10.  A rare case of type 3 usher syndrome with bilateral cystoid macular edema treated with topical dorzolamide.

Authors:  Athul Puthalath; Ramanuj Samanta; Neeraj Saraswat; Ajai Agrawal; Anupam Singh; Mahsa Jamil
Journal:  Taiwan J Ophthalmol       Date:  2020-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.